ADMA Biologics, Inc. (ADMA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for ADMA Biologics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 29.58x | 20.22x | -35.85x | -11.65x | -2.75x | -2.22x |
| P/B Ratio | 9.11x | 11.45x | 7.49x | 5.05x | 1.39x | 1.90x |
| P/S Ratio | 8.52x | 9.37x | 3.92x | 4.98x | 2.43x | 3.98x |
| Profitability | ||||||
| Gross Margin | 57.4% | 51.5% | 34.4% | 22.9% | 1.4% | -45.2% |
| Operating Margin | 37.5% | 32.6% | 8.4% | -25.5% | -72.1% | -153.8% |
| Net Margin | 28.8% | 46.4% | -10.9% | -42.8% | -88.5% | -179.4% |
| EBITDA Margin | 38.8% | 34.6% | 2.0% | -25.6% | -65.6% | -141.7% |
| Liquidity | ||||||
| Current Ratio | 6.71x | 5.97x | 5.16x | 6.89x | 6.87x | 7.71x |
| Quick Ratio | 3.74x | 2.90x | 1.69x | 2.73x | 2.77x | 3.62x |
| Leverage | ||||||
| Debt/Equity | 0.17x | 0.24x | 1.05x | 1.02x | 0.73x | 1.11x |
YoY = year-over-year change. Source: FMP..